EP1986612
Stöðluð samsetning glúkócerebrosidasa
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.2.2007EP published:
12.9.2012EP application number:
07763599.3
EP translation filed:
15.11.2012Grant published:
15.12.2012EPO information:
European Patent Register
Max expiry date:
5.2.2027Expiry date:
5.2.2027
Title:
Stabilized composition of glucocerebrosidase
Timeline
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
ZHU, GaozhongAddress:
Arlington, MA, US
Name:
LOWE, KrisAddress:
Boston, MA, US
Name:
SHAHROKH, ZahraAddress:
Weston, MA, US
Name:
NGUYEN, VinhAddress:
Chelsea, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
771555 PDate:
7.2.2006Country:
US
Classification
Categories:
A61K 9/19, A61K 9/00, A61K 47/10, A61K 47/12, A61K 47/20, A61K 47/26, A61P 43/00, A61K 38/47
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 21.1.2013
Expires: 5.2.2014
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 21.1.2014
Expires: 5.2.2015
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 20.1.2015
Expires: 5.2.2016
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 20.1.2016
Expires: 5.2.2017
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.1.2017
Expires: 5.2.2018
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 22.1.2018
Expires: 5.2.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 13
Paid: 22.1.2019
Expires: 5.2.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 14
Paid: 22.1.2020
Expires: 4.2.2021
Payer: Patice ehf.
Number: 15
Paid: 20.1.2021
Expires: 5.2.2022
Payer: Patice ehf.
Number: 16
Paid: 19.1.2022
Expires: 5.2.2023
Payer: Patice ehf.
Number: 17
Paid: 19.1.2023
Expires: 5.2.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 23.1.2024
Expires: 5.2.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 24.1.2025
Expires: 5.2.2026
Payer: Árnason Faktor ehf.
Number: 20
Paid: 4.2.2026
Expires: 5.2.2027
Payer: Árnason Faktor ehf.